Literature DB >> 10479177

Virulence characteristics of Escherichia coli in acute bacterial prostatitis.

K Mitsumori1, A Terai, S Yamamoto, S Ishitoya, O Yoshida.   

Abstract

To assess the urovirulence characteristics of Escherichia coli strains causing acute prostatitis, urinary isolates from men with acute prostatitis (n=107) and from women with acute uncomplicated pyelonephritis (n=76) were examined for the prevalence of sfa, foc, and 3 papG allele genotypes and phenotypes and for the production of alpha-hemolysin and cytotoxic necrotizing factor 1. The papG allele III and foc gene were found more frequently and the papG allele II less frequently among prostatitis than from pyelonephritis isolates. A higher proportion of hly+ cnf1+ genotype in prostatitis strains (64% vs. 36%) was particularly striking. Both prostatitis and pyelonephritis strains expressed virulence factors similarly except for a higher proportion of nonhemolytic prostatitis isolates. Although the pathogenetic mechanisms of urinary tract infections in men and women may differ, virulence factors such as adhesins and cytotoxins may have important roles in the pathogenesis of acute prostatitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479177     DOI: 10.1086/314976

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.

Authors:  W Thomas; Z K Ascott; D Harmey; L W Slice; E Rozengurt; A J Lax
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 2.  CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors.

Authors:  Mengfei Ho; Amel Mettouchi; Brenda A Wilson; Emmanuel Lemichez
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

3.  Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection.

Authors:  James R Johnson; Flemming Scheutz; Peter Ulleryd; Michael A Kuskowski; Timothy T O'Bryan; Torsten Sandberg
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism.

Authors:  M Mills; K C Meysick; A D O'Brien
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Acute bacterial inflammation of the mouse prostate.

Authors:  Bayli J Boehm; Sara A Colopy; Travis J Jerde; Christopher J Loftus; Wade Bushman
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

6.  Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.

Authors:  May Khalili; Laura N Mutton; Bora Gurel; Jessica L Hicks; Angelo M De Marzo; Charles J Bieberich
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

7.  Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model.

Authors:  K E Rippere-Lampe; M Lang; H Ceri; M Olson; H A Lockman; A D O'Brien
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli.

Authors:  K C Meysick; M Mills; A D O'Brien
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

9.  Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate.

Authors:  J E Elkahwaji; R J Hauke; C M Brawner
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

10.  A host defense mechanism involving CFTR-mediated bicarbonate secretion in bacterial prostatitis.

Authors:  Chen Xie; Xiaoxiao Tang; Wenming Xu; Ruiying Diao; Zhiming Cai; Hsiao Chang Chan
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.